To view this email as a web page, click here.
August 24, 2018
 
ISSUE ALERT
Volume 43, Issue 13
Special Report: Targeted therapy for ocular melanoma
Check out the digital edition!
 
How surgeons are practicing in 2018: Global trends
image description here From first-line anti-VEGF choice for AMD to learning a new surgical technique via video, the results from a 2018 global trends in retina survey are out. Rishi P. Singh, MD, shares.

Read more
 
Targeted therapy for ocular melanoma
image description here Amy C. Schefler, MD, explains how light-activated AU-011 has the potential to be the first targeted therapy ever developed for the primary treatment of ocular melanoma. Learn how the novel therapy, which disrupts the tumor cell membrane and causes acute cellular necrosis, can help patients.

Read more
 
Why do we have such a hard time sitting still?
image description here OT’s chief medical editor, Peter J. McDonnell, MD, discusses the reasons why people would rather shock themselves than be still in his latest editorial. Learn why it’s important to take a step back and relax.

Read more
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.